Donald Nyanhongo

Donald Nyanhongo

Auto-generated profile, based on publicly available information

Donald Nyanhongo

Russells Hall Hospital, The Dudley Group NHS Foundation Trust, UK

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in Annals of Surgery
Verified
Journal Article
Closed access
SPSandro Pasquali
Sandro Pasquali
GYGuang Yim
Guang Yim
RVRavinder S. Vohra
Ravinder S. Vohra
SMSimone Mocellin
Simone Mocellin
DNDonald Nyanhongo
Donald Nyanhongo
EGEwen Griffiths
Ewen Griffiths
This network meta-analysis compared overall survival after neoadjuvant or adjuvant chemotherapy (CT), radiotherapy (RT), or combinations of both (chemoradiotherapy, CRT) or surgery alone to identify the most effective approach. The optimal treatment for resectable esophageal cancer is unknown. A search for randomized controlled trials reporting on neoadjuvant and adjuvant therapies was conducted. Using a network meta-analysis, treatments were ranked based on their effectiveness for improving survival. In 33 eligible randomized controlled trials, 6072 patients were randomized to receive either surgery alone (N = 2459) or neoadjuvant CT (N = 1332), RT (N = 58), and CRT (N = 1196) followed by surgery or surgery followed by adjuvant CT (N = 542), RT (N = 383), and CRT (N = 102). Twenty-one comparisons were generated. Neoadjuvant CRT followed by surgery compared with surgery alone was the only treatment to significantly improve survival [hazard ratio (HR) = 0.77, 95% confidence interval (CI): 0.68–0.87]. When trials were grouped considering neoadjuvant and adjuvant therapies and surgery alone, neoadjuvant therapies combined with surgery compared with surgery alone showed a survival advantage (HR = 0.83, 95% CI 0.76–0.90), whereas surgery along with adjuvant therapies showed no significant survival advantage (HR = 0.87, 95% CI 0.67–1.14). A subgroup analysis of neoadjuvant therapies showed a superior effectiveness of neoadjuvant CRT and surgery compared with surgery alone (HR = 0.77, 95% CI 0.68–0.87). This network meta-analysis showed neoadjuvant CRT followed by surgery to be the most effective strategy in improving survival of resectable esophageal cancer. Resources should be focused on developing the most effective neoadjuvant CRT regimens for both adenocarcinomas and squamous cell carcinomas of the esophagus.

3 February 2017 in International Journal of Surgery
Verified
Journal Article
Closed access
PDF file
ABAditya Borakati
Aditya Borakati
KMKenneth McLean
Kenneth McLean
TDThomas M. Drake
Thomas M. Drake
EHEwen M. Harrison
Ewen M. Harrison
SKSivesh Kamarajah
Sivesh Kamarajah
AZAdreana Zulkifli
Adreana Zulkifli

13 June 2017 in BMJ Case Reports
Verified
Journal Article
Closed access
PDF file
DNDonald Kudakwashe Nyanhongo
Donald Kudakwashe Nyanhongo
SASatpal Antil
Satpal Antil
SNSyed Nasir
Syed Nasir
A duplex ureter constitutes about 1% of the renal tract anomalies. A 39-year-old man presented with a 4-week history of left loin pain and microscopic haematuria. Investigation with a non-contrast CT KUB revealed a 6 mm non-obstructing calculus in the left distal ureter. Left ureteroscopy and lithotripsy was planned. However, ureteroscopy failed to identify the calculus. A double J ureteric stent was left in situ and the procedure abandoned in favour of further assessment with a CT urogram. Imaging surprisingly showed a left duplex ureter with the calculus in the non-stented ureter. Repeat ureteroscopy noted the second ureter opening within the distal intramural part of the stented ureter. The calculus was identified and laser lithotripsy performed. A double J stent was appropriately reinserted and removed 2 weeks later. Our case highlights the importance of contrasted imaging prior to performing ureteroscopy for calculus disease.

23 March 2016 in International Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
SAShweta Aggarwal
Shweta Aggarwal
SMSekhar Marla
Sekhar Marla
DNDonald Nyanhongo
Donald Nyanhongo
SKSita Kotecha
Sita Kotecha
NBNarendra Nath Basu
Narendra Nath Basu
Introduction. Therapeutic mammaplasty (TM) is a useful technique in the armamentarium of the oncoplastic breast surgeon (OBS). There is limited guidance on patient selection, technique, coding, and management of involved margins. The practices of OBS in England remain unknown. Methods. Questionnaires were sent to all OBS involved with the Training Interface Group. We assessed the number of TM cases performed per surgeon, criteria for patient selection, pedicle preference, contralateral symmetrisation, use of routine preoperative MRI, management of involved margins, and clinical coding. Results. We had an overall response rate of 43%. The most common skin resection technique utilised was wise pattern followed by vertical scar. Superior-medial pedicle was preferred by the majority of surgeons (62%) followed by inferior pedicle (34%). Twenty percent of surgeons would always proceed to a mastectomy following an involved margin, whereas the majority would offer reexcision based on several parameters. The main absolute contraindication to TM was tumour tobreast ratio >50%. One in five surgeons would not perform TM in smokers and patients with multifocal disease. Discussion. There is a wide variation in the practice of TM amongst OBS. Further research and guidance would be useful to standardise practice, particularly management of involved margins and coding for optimal reimbursement. Introduction. Therapeutic mammaplasty (TM) is a useful technique in the armamentarium of the oncoplastic breast surgeon (OBS). There is limited guidance on patient selection, technique, coding, and management of involved margins. The practices of OBS in England remain unknown. Methods. Questionnaires were sent to all OBS involved with the Training Interface Group. We assessed the number of TM cases performed per surgeon, criteria for patient selection, pedicle preference, contralateral symmetrisation, use of routine preoperative MRI, management of involved margins, and clinical coding. Results. We had an overall response rate of 43%. The most common skin resection technique utilised was wise pattern followed by vertical scar. Superior-medial pedicle was preferred by the majority of surgeons (62%) followed by inferior pedicle (34%). Twenty percent of surgeons would always proceed to a mastectomy following an involved margin, whereas the majority would offer reexcision based on several parameters. The main absolute contraindication to TM was tumour tobreast ratio >50%. One in five surgeons would not perform TM in smokers and patients with multifocal disease. Discussion. There is a wide variation in the practice of TM amongst OBS. Further research and guidance would be useful to standardise practice, particularly management of involved margins and coding for optimal reimbursement.

7 August 2023 in Journal of Clinical Urology
Verified
Journal Article
Closed access
PSPiyush B Sarmah
Piyush B Sarmah
W–West Midlands Urology Research Collaborative HEATT study group –
West Midlands Urology Research Collaborative HEATT study group –
WAWesam Al-Dhahir
Wesam Al-Dhahir
ACAkhil Chellapuri
Akhil Chellapuri
ADAdebiyi Damola
Adebiyi Damola
ACAniruddha Chakravarti
Aniruddha Chakravarti
Objective: To calculate the re-admission rate with haematuria within 30 days of elective transurethral resection of bladder tumour (TURBT), and identify factors associated with this. Materials and Methods: This was a multicentre, retrospective audit, identifying all adult patients over the age of 16 who underwent elective TURBT between 1 September and 30 November 2019. Data were collected from medical records and operation notes on patient demographics, intra-operative factors and post-operative management. Primary outcome measure was the proportion of patients emergently re-admitted with haematuria. Secondary outcome measures were the re-operation rate for haematuria, and the rate of new acute thrombotic event (TE). Fisher’s exact test was used to calculate p values within subgroups for re-admission rates. Results: 443 patients from 12 hospitals were included. Median age was 75 years (17–99). 15 patients (3.4%) were re-admitted with haematuria. Subgroup analysis demonstrated higher rate of re-admission for pre-existing antithrombotic agents (ATAs) (2.0% vs. 6.1%, p = 0.046), increased for non-Aspirin ATAs (10.5%, p = 0.0015). 52% of non-Aspirin ATAs were restarted within 48 hours of surgery; post-operative plan for restarting was not documented in 22.1%. One patient (0.23%) developed acute TE (pulmonary embolus). Conclusion: Pre-existing use of non-Aspirin ATAs is associated with increased risk of post-TURBT haematuria, with variable practice in post-operative recommencement. Level of evidence: Level 3

14 December 2020 in Journal of the International Society for Telemedicine and eHealth
Verified
Journal Article
Open access
PDF file
DNDonald Kudakwashe Nyanhongo
Donald Kudakwashe Nyanhongo
Objectives: Health services have been disrupted due to Coronavirus disease 2019 (COVID-19). With patients, unable to access face to face healthcare, many turn to sources such as the Internet for health-related information. Other patients ignore all other health related issues and focus on the threat posed by a pandemic. This study sought to analyse the Internet health-seeking behaviour related to urological cancer of patients in the United Kingdom (UK) during the COVID-19 Pandemic. Methods: Internet search volumes over a 3-month period, during the UK pandemic, were analysed using Google TrendsTM to obtain a search volume index (SVI) and compared to an equivalent pre COVID-19 period. The SVI measures relative search volume and was obtained for “Prostate Cancer”, “Kidney Cancer”, “Bladder Cancer” and Testicular Cancer” searches. Results: The average SVI for Prostate Cancer before the COVID-19 pandemic was 49.3, compared to 42.6 during the pandemic (p=0.001). Kidney cancer had an average SVI of 45.5 before the pandemic compared to 35.4 during the pandemic (p <0.001). Similar results were obtained for Bladder and Testicular Cancer. There was a 23% decrease in SVI for urological cancer searches during the pandemic compared to before the pandemic (p <0.001). Conclusions: The decline in searches for urological cancer during the pandemic may have implications. Patients maybe ignoring new cancer related symptoms which could result in late diagnoses, public health campaigns are required. Patients with cancer may not be utilising online resources available to them and healthcare professionals should reach out to patients at a time when face-face interaction is limited.